Published in Clin Pharmacol Ther on April 01, 1982
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia. Vasc Health Risk Manag (2009) 0.87
Niacin: another look at an underutilized lipid-lowering medication. Nat Rev Endocrinol (2012) 0.86
Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res (2010) 0.81
Effect of niacin on the choroidal circulation of patients with age related macular degeneration. Br J Ophthalmol (2004) 0.76
Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics. J Lipid Res (2017) 0.75
Clinical and laboratory responses to niceritrol in the treatment of hypercholesterolaemia. Postgrad Med J (1988) 0.75
Effects of aspirin upon the flushing reaction induced by niceritrol. Br J Clin Pharmacol (1990) 0.75
Management and Prevention of Anaphylaxis. F1000Res (2015) 0.75
Effect of oral niacin on central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Rosacea. Pathophysiology and treatment. Arch Dermatol (1994) 2.86
Evaluation of the updated Vitek yeast identification data base. J Clin Microbiol (1990) 2.45
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1994) 1.96
The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol (1980) 1.76
Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest (1995) 1.75
Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas. Int J Oncol (1998) 1.62
Azelaic acid esters do not depigment pigmented guinea pig skin. Arch Dermatol (1990) 1.37
Unilateral dermatomal superficial telangiectasia. Nine new cases and a review of unilateral dermatomal superficial telangiectasia. J Am Acad Dermatol (1983) 1.10
Chemotherapy for high-grade gliomas. Br J Cancer (2000) 1.09
Hidrocystomas. Arch Dermatol (1973) 1.06
Prostaglandins and nicotinate-provoked increase in cutaneous blood flow. Clin Pharmacol Ther (1985) 1.05
Disseminated superficial actinic porokeratosis (DSAP). Arch Dermatol (1967) 1.01
Flushing reactions: consequences and mechanisms. Ann Intern Med (1981) 0.97
Disseminated superficial actinic porokeratosis. Genetic aspects. Arch Dermatol (1969) 0.97
Molluscum contagiosum venereum in a women's outpatient clinic: a venereally transmitted disease. Am J Obstet Gynecol (1977) 0.94
Porokeratosis. Arch Dermatol (1986) 0.94
The effects of cutting or of stretching skeletal muscle in vitro on the rates of protein synthesis and degradation. Biochem J (1980) 0.94
Trichorrhexis nodsa--an error of amino acid metabolism? J Invest Dermatol (1967) 0.94
A survey of available nitrogen sources for growth of the blue-green alga, Agmenellum quadruplicatum. Arch Microbiol (1975) 0.91
Current status of bioassays in genetic toxicology--the dominant lethal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res (1985) 0.91
Squamous cell and basal cell carcinomas: preliminary study of 3,817 primary skin cancers. South Med J (1978) 0.90
Perifollicular fibroma. Arch Dermatol (1969) 0.89
Trichorrhexis nodosa. Clinical and investigative studies. Arch Dermatol (1966) 0.89
Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol (1981) 0.89
Eczema herpeticum in association with familial benign chronic pemphigus. J Am Acad Dermatol (1993) 0.88
Nodular colloid degeneration: distinctive histochemical and ultrastructural features. Cutis (1985) 0.87
Disseminated superficial actinic porokeratosis. Clinical studies and experimental production of lesions. Arch Dermatol (1969) 0.87
Rosacea. Int J Dermatol (1983) 0.86
Iododerma occurring during thyroid protection treatment. Cutis (1985) 0.86
Correlations between laboratory testing and distance running performance in marathoners of similar performance ability. Int J Sports Med (1983) 0.86
Squaric acid and esters: analysis for contaminants and stability in solvents. J Am Acad Dermatol (1985) 0.86
Pityriasis rosea-like rash from captopril. Arch Dermatol (1982) 0.86
Reactive perforating collagenosis of diabetes mellitus and renal failure. Cutis (1983) 0.86
Familial progressive hyperpigmentation. Arch Dermatol (1971) 0.85
Clinical recognition of clear-cell acanthoma (Degos'). Arch Dermatol (1969) 0.85
Unilateral dermatomal superficial telangiectasia. Dermatologica (1978) 0.85
Elephantiasis nostras of the abdominal wall. Arch Dermatol (1966) 0.85
Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry (1998) 0.84
Immunological biomarkers: catalysts for translational advances in autoimmune diabetes. Clin Exp Immunol (2013) 0.84
Yellow nail syndrome in patients with acquired immunodeficiency disease. J Am Acad Dermatol (1985) 0.83
Squamous cell carcinoma in lesions of disseminated superficial actinic porokeratosis: a report of two cases. Arch Dermatol (1986) 0.83
Treatment of leishmaniasis with sodium antimony gluconate: transient ECG findings. South Med J (1978) 0.82
Failure of drug rash to appear in a previously irradiated site. Arch Dermatol (1981) 0.82
Bier's spots reconsidered: a tale of two spots, with speculation on a humerus vein. J Am Acad Dermatol (1986) 0.82
Teratology and percutaneous toxicity studies on hair dyes. J Toxicol Environ Health (1976) 0.81
A quantitative, non-invasive method for the characterization of flushing reactions. J Invest Dermatol (1982) 0.80
Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate. J Dermatol Surg Oncol (1994) 0.80
Vascular abnormalities in lichen aureus. J Am Acad Dermatol (1983) 0.80
Adverse side-effects after topical fluorinated corticosteroid therapy. Arch Dermatol (1973) 0.80
Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. J Immunol (1998) 0.80
Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol (1983) 0.78
Collagen implant in management of perlèche (angular cheilosis). J Am Acad Dermatol (1985) 0.78
Periodic cutaneous blood flow during postocclusive reactive hyperemia. Am J Physiol (1986) 0.78
Trichorrhexis nodosa; in vitro reproduction. Arch Dermatol (1966) 0.78
An unusual case of calcinosis cutis. J Am Acad Dermatol (1983) 0.78
Apocrine hidrocystoma (cystademnoma). Arch Dermatol (1974) 0.78
Cutaneous reactions to lower aliphatic alcohols before and during disulfiram therapy. Arch Dermatol (1982) 0.77
Disseminated superficial actinic porokeratosis (DSAP). Int J Dermatol (1973) 0.77
Substrate specificity of human cutaneous alcohol dehydrogenase and erythema provoked by lower aliphatic alcohols. J Invest Dermatol (1987) 0.77
Acquired persistent erythematous patch on the neck. Acquired nevus flammeus. Arch Dermatol (1994) 0.76
Ethnic contact urticaria to alcohol. Contact Dermatitis (1985) 0.76
Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry (1997) 0.76
Porokeratosis: report of twelve patients with multiple superficial lesions. South Med J (1966) 0.76
Quantitative assessment of alcohol-provoked flushing. Arch Dermatol (1986) 0.76
Cutaneous vascular sensitivity to lower aliphatic alcohols and aldehydes in Orientals. Alcohol Clin Exp Res (1985) 0.76
Perilesional heparin injections for necrobiosis lipoidica. J Am Acad Dermatol (1983) 0.76
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract. Cancer Treat Rep (1987) 0.76
Tennis elbow and life-style factors. Postgrad Med (1990) 0.75
Pruritus in sickle cell disease: response to cholestyramine. J Natl Med Assoc (1977) 0.75
Re: chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (2000) 0.75
Potential subversion of pregnancy prevention program in the managed care setting. Arch Dermatol (1997) 0.75
Permanent removal of superfluous hair. Tex Med (1971) 0.75
Use of topical products for maintaining remission in rosacea. Arch Dermatol (1999) 0.75
Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability. J Am Acad Dermatol (1984) 0.75
Diaper dermatitis. Am Fam Physician (1982) 0.75
Periorbital hyperpigmentation. JAMA (1981) 0.75
Motor activity effects in female Fischer 344 rats exposed to isopropanol for 90 days. J Appl Toxicol (1999) 0.75
Leprosy. Am Fam Physician (1982) 0.75
Cimetidine and tetracycline in acne. J Am Acad Dermatol (1982) 0.75
Isopropanol vapor inhalation oncogenicity study in Fischer 344 rats and CD-1 mice. Fundam Appl Toxicol (1997) 0.75
Unilateral dermatomal cavernous hemangiomatosis. Dermatologica (1980) 0.75
Porphyria cutanea tarda in a chronic hemodialysis patient. South Med J (1980) 0.75
Bilateral, nonsymmetric dermatomal nevi flammei. Arch Dermatol (1979) 0.75
Chronic benign familial pemphigus. Minimal involvement mimicking chronic perianal candidiasis. Arch Dermatol (1978) 0.75
A new dietary paradiagm? S Afr Med J (2014) 0.75
Telangiectatic erythema with congenital anomalies. Int J Dermatol (1980) 0.75
Chlorpropamide-alcohol flushing, malar thermal circulation index, and baseline malar temperature. Metabolism (1982) 0.75
Infrared photographic studies of rosacea. Arch Dermatol (1980) 0.75
[Plasma dopamine, noradrenaline and adrenaline response during cardiac and peripheral-muscular exhaustion]. Int Arch Occup Environ Health (1983) 0.75
Scarification treatment of granuloma annulare. Arch Dermatol (1982) 0.75
Blockade of carcinoid flush with cimetidine and clonidine. Arch Dermatol (1982) 0.75
Epigastric rosacea. Arch Dermatol (1980) 0.75
Nicotinic acid treatment of skin disorders. Br J Dermatol (1979) 0.75
The role of mononitrochlorobenzene as a contaminant in dinitrochlorobenzene. J Am Acad Dermatol (1982) 0.75
Unilateral nevoid telangiectasia: three new cases and the role of estrogen. Arch Dermatol (1977) 0.75
Vasodilator rosacea. Arch Dermatol (1980) 0.75
Vascular factors and the localization of varicella lesions. J Am Acad Dermatol (1981) 0.75
Letter: Facial flushing is not blushing. N Engl J Med (1976) 0.75
University of Texas Health Science Center at Houston. Cutis (1983) 0.75
Acanthoma fissuratum cutis. Report of a case and a review of previous cases. J Dermatol Surg Oncol (1978) 0.75